A federal jury ordered Medtronic to hand a competitor about $382 million after ruling the Minnesota-run medtech company violated anti-monopoly laws by selling technology to hospitals with unlawfully ...

Its shares have lost a third of their value since mid-2021, lifting the dividend yield up to 3.1%. The company's growth has stalled out, but management is working on the issue. Medtronic is about to ...

Medtronic's surgical device sales decline due to inventory issues CEO Martha monitors impact of Trump's tariffs Shares down more than 7% in morning trade Feb 18 (Reuters) - Medtronic (MDT.N), opens ...

Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical robotics. Got a confidential news tip? We want to hear from you. Sign up for free ...

Medtronic boasts strong free cash flow, stable dividends, and innovation focus, but faces macro headwinds, high debt, and competitive pressures. Recent strategic portfolio moves, including spin-offs ...

Medtronic’s stock sat on the discount rack for years. Then, in August, a well-known activist investor finally took the bait, buying a sizeable stake in the nation’s largest medical device company and ...

The stock is especially attractive to income seekers.